SURI Price Forecast & ETF Analysis. Dividend · Expense Ratio · Holdings · NAV · RSI · MACD | US Stocks Today
Full metrics table
| Category | Target Date / Multi-Asset - Other | Expense | 2.56% | Return% 1Y | 39.05% | Total Holdings | 40 | Perf Week | -9.37% | Volume | 2,018 |
| Asset Type | Multi-Asset - Tactical / Active | AUM | $80M | Return% 3Y | 11.78% | NAV | $18.49 | Perf Month | -14.36% | Avg Volume | 0.00M |
| ETF Type | Global Diversified | Dividend TTM | $2.72 (15.52%) | Return% 5Y | - | 52W High | -17.74% | Perf Quarter | 1.04% | Rel Volume | 0.54 |
| Active/Passive | Active | Div Gr. 3/5Y | - | Return% 10Y | - | 52W Low | 17.65% | Perf Half Y | 11.84% | Prev Close | $18.70 |
| IPO | 2023/2/10 | Flows% 1M | 0.48% | Return% SI | 7.58% | RSI (14) | 25.75 | Perf YTD | 5.13% | Price | $17.53 |
| Beta | 1.17 | Flows% 3M | 1% | Flows% YTD | -3.12% | Flows% 1Y | -2.53% | Perf Year | 12.67% | Volatility(W/M) | 1.91% 1.48% |
| SMA20 | -9.97% | SMA50 | -7.88% | SMA200 | -0.28% | ATR | 0.41 | ||||
Simplify Propel Opportunities ETFSURI | NYSE | Dividend income Simplify Propel Opportunities ETF seeks to provide long-term growth of capital. The fund is an actively managed exchange-traded fund. The Sub-Adviser concentrates the fund's investments (i.e., invests more than 25% of its net assets) in the securities of issuers in the biotechnology, pharmaceuticals, healthcare technology, and life science tools and services industries. The Sub-Adviser employs an actively managed opportunistic multi-asset strategy that focuses on common stock, preferred stock, convertible bonds, structured notes, corporate notes and bonds, and ETFs that primarily invest in the preceding security types. The fund is non-diversified.
The top 10 make up 157% of the fund
PAGP PLAINS GP HOLDINGS LP 39.97% 3 
ACHV ACHIEVE LIFE SCIENCES INC 16.53% 4 
MIST MILESTONE PHARMACEUTICALS INC 5.81% 5 
DCTH DELCATH SYSTEMS INC 4.26% 6 
PHAT PHATHOM PHARMACEUTICALS INC 3.50% 7 
CORT CORCEPT THERAPEUTICS INC 2.98% 8 
ABEO ABEONA THERAPEUTICS INC 2.76% 9 
CLDX CELLDEX THERAPEUTICS INC 2.56% 10 
KYTX KYVERNA THERAPEUTICS INC 2.11% Over the past 1 year, roughly in the middle
18% below its 1-year high.
Traded less than usual That is 54% of its average volume.
Long-term returns are roughly flat
Bought 3 years ago, your return today would be -15.0%.
Tap to view numbers
The price swings a lot
At its worst (November 2024) it fell 48% and has not fully recovered yet.
Tap to view numbers
Dividends are paid consistently
Pays 15.52% annually in dividends.
Tap to view numbers
A little money is flowing out
Over the past year, money equal to 2.5% of assets left.
Tap to view numbers
IAGG-1× iShares International Aggregate Bond Fund 11.7B 
SPYU MAX S&P 500 4X Leveraged ETN 554M 
LQDW iShares Investment Grade Corporate Bond BuyWrite Strategy ETF 340M 
TBT-1× ProShares UltraShort 20+ Yr Treasury 335M 
WEEK Roundhill Weekly T-Bill ETF 190M 
CGBL Capital Group Core Balanced ETF 0.33% 
IALT iShares Systematic Alternatives Active ETF 0.99% 
ALLW State Street Bridgewater All Weather ETF 0.85% 
DRSK Aptus Defined Risk ETF 0.79% 
CTA Simplify Managed Futures Strategy ETF 0.75% 
UCBG State Street SPDR UC Investments 90/10 Endowment Strategy Index ETF 0.06% 
CTAP Simplify US Equity PLUS Managed Futures Strategy ETF 0.1% 
ITDC iShares LifePath Target Date 2035 ETF 0.1% 
FAQ
How many holdings does SURI have?
SURI holds a total of 40 securities, with an AUM of approximately $80M.
Does SURI pay dividends (distributions)?
SURI's distribution yield is approximately 15.52%.
What is the 52-week high and low for SURI?
SURI has recorded a 52-week high of $21.31 and a low of $14.90.
